These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7363420)
1. Synthesis and pharmacology of a noncompetitive antagonist of angiotensin-induced contractions of vascular smooth muscle. [Sarcosyl]1-[cysteinyl (s-methyl)]8-angiotensin II. Freer RJ; Sutherland JC; Day AR Circ Res; 1980 May; 46(5):720-5. PubMed ID: 7363420 [TBL] [Abstract][Full Text] [Related]
2. Organ selective angiotensin antagonists: sarcosyl1-cysteinyl(S-methyl)8-angiotensin I. Freer RJ; Sutherland JC; Day AR Eur J Pharmacol; 1980 Aug; 65(4):349-54. PubMed ID: 7408944 [TBL] [Abstract][Full Text] [Related]
3. A potent noncompetitive angiotensin II antagonist induces only competitive inhibition of angiotensin III responses. Trachte GJ; Peach MJ J Cardiovasc Pharmacol; 1983; 5(6):1025-33. PubMed ID: 6196550 [TBL] [Abstract][Full Text] [Related]
4. Antagonist effect of losartan on angiotensin II induced contraction in five isolated smooth muscle assays. Liu YJ Eur J Pharmacol; 1993 Aug; 240(2-3):147-54. PubMed ID: 8243534 [TBL] [Abstract][Full Text] [Related]
5. Sarmesin is a partial agonist of angiotensin-II receptors in rabbit, but not in rat, aortic rings. Criscione L; Thomann H; Whitebread S; de Gasparo M; Kamber B Biochem Biophys Res Commun; 1990 Jun; 169(2):636-42. PubMed ID: 2357223 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacology of a prohormone angiotensin antagonist. Chiu AT; Sutherland JC; Day AR; Freer RJ Eur J Pharmacol; 1979 Feb; 54(1-2):177-80. PubMed ID: 421740 [TBL] [Abstract][Full Text] [Related]
7. Calcium and angiotensin tachyphylaxis in rat uterine smooth muscle. Freer RJ Am J Physiol; 1975 May; 228(5):1423-30. PubMed ID: 236670 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist. Paiva AC; Nouailhetas VL; Paiva TB J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965 [TBL] [Abstract][Full Text] [Related]
9. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release. Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388 [TBL] [Abstract][Full Text] [Related]
10. An angiotensin II antagonist with strongly prolonged action. Holck M; Bossé R; Fischli W; Gerold H; Escher E Biochem Biophys Res Commun; 1989 May; 160(3):1350-6. PubMed ID: 2730646 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist. Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838 [TBL] [Abstract][Full Text] [Related]
12. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations. Karasawa A; Shirakura S; Higo K; Kubo K Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues. Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777 [TBL] [Abstract][Full Text] [Related]
14. Nonpeptide angiotensin II receptor antagonists. IV. EXP6155 and EXP6803. Wong PC; Price WA; Chiu AT; Thoolen MJ; Duncia JV; Johnson AL; Timmermans PB Hypertension; 1989 May; 13(5):489-97. PubMed ID: 2656519 [TBL] [Abstract][Full Text] [Related]
15. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci. Karaki H; Nagase H; Ozaki H; Urakawa N; Weiss GB Br J Pharmacol; 1986 Oct; 89(2):423-9. PubMed ID: 3779218 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277. Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of angiotensin II and heptapeptide on smooth muscle (vascular and uterine). Moore AF; HAll MM; Khairallah PA Eur J Pharmacol; 1976 Sep; 39(1):101-7. PubMed ID: 183963 [TBL] [Abstract][Full Text] [Related]
18. Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta with the novel competitive antagonist sarmesin. Scanlon MN; Moore GJ Pharmacology; 1988; 37(3):137-47. PubMed ID: 3227047 [TBL] [Abstract][Full Text] [Related]
19. The competitive antagonistic effect of compounds from Mandevilla velutina on kinin-induced contractions of rat uterus and guinea-pig ileum in vitro. Calixto JB; Pizzolatti MG; Yunes RA Br J Pharmacol; 1988 Aug; 94(4):1133-42. PubMed ID: 3207977 [TBL] [Abstract][Full Text] [Related]
20. Effect of tyrosine ionization upon biological activities of angiotensin II and two new peptide analogues. Nakaie CR; Oshiro ME; Goissis G; Paiva AC Biochim Biophys Acta; 1977 Nov; 495(1):151-8. PubMed ID: 20979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]